![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, April 23, 2024 3:25:53 PM
ALLEN, TX / ACCESSWIRE / April 23, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) (enzolytics.com)(the "Company") today disclosed that on April 9, 2024, the US District Court of Nevada dismissed the lawsuit, 22-cv-00401-GMN-DJA brought by Dimitar Savov against IMMB bringing to an end the claims alleged in this suit. Originally filed on March 3, 2022 against the corporation that ENZC had its assets, including ITV-1, IMMB and ENZC have successfully defended their position against the plaintiff through 2 years of litigation. Enzolytics will continue to aggressively defend any litigation.
Updating the progress on the December 31, 2023, OTC annual report the Company has completed its disclosure and financial statements and is waiting for an administrative issue to be resolved with OTC Markets. Because of the change of directors, a change in control had to be filed with OTC and the Company has done that, paid the fees, and is awaiting final approval. The Company is in contact with OTC Market representatives and expects the process to be completed with the uploading of the report to immediately following its resolution. The Company has discovered and corrected several other administrative issues in the past weeks and expects to resolve any remaining items soon.
The ENZC website, which was taken down by someone other than the Company, is being brought back online as quickly as possible and will be updated shortly for the changes in directors and officers and a copy of the disclosures and financial statements for December 31, 2023, will be published there. The Company has a new X/Twitter profile: @EnzolyticsInc.
Management has further defined the new direction being undertaken by ENZC. Negotiations have been entered into with potential partners and suppliers for the development of a strategy to provide sales, marketing and distribution services for Medical Devices, Nutraceutical and Medical Testing Technology. ENZC expects to enter into licensing, acquisition and partnership agreements from its current efforts.
"This is a victory for ENZC and brings to a close a legal battle. ENZC will continue to defend itself against all claims made by any and all plaintiffs trying to harm the company and the underlying Shareholder value", said Steve Sharabura, Interim CEO. "I am also appreciative of the progress we, as a team, are making in the implementation of the new business model focusing licensing, acquiring and partnering with entities in the medical devices, medical testing and nutraceutical products markets."
![Bullish](/static/images/ih2-bull.png)
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results • SNWV • Aug 13, 2024 7:11 AM
Kona Gold Beverages, Inc. Nears Completion of Reverse Merger with New Candidate • KGKG • Aug 12, 2024 10:00 AM
Maybacks Global Entertainment and DigiTrax Entertainment Sign Agreement to Broadcast "Karaoke Cloud" on iDreamCTV • AHRO • Aug 12, 2024 8:45 AM
HealthLynked Partners with RxSpark to Enhance Medication Access and Management for Patients • HLYK • Aug 12, 2024 8:00 AM
Maybacks Global Entertainment and ZEASN Technology Private Ltd. Sign Global Licensing Agreement • AHRO • Aug 8, 2024 7:00 AM
SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results • SNWV • Aug 8, 2024 6:59 AM